M. Cusnir

发表

Cabazitaxel for Metastatic Castrate-Resistant Prostate Cancer: A Case Presentation

S. Zeichner, M. Cusnir, M. Francavilla, 2012 .

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

J. Berlin, A. Jimeno, D. Aisner, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Analysis of Genetic Alterations in Cutaneous Malignant Melanomas Unveils Unique Loco-Regional Variations and Novel Predictors of Metastatic Potential

R. Poppiti, M. Cusnir, S. Alghamdi, 2021, The American Journal of dermatopathology.

Novel Systemic Therapy Options for Hepatocellular Carcinoma

M. Cusnir, Y. Patt, 2004, Cancer journal.

Typical Bronchial Carcinoid Metastasizing to the Brain: A Case Presentation

S. Zeichner, M. Cusnir, M. Francavilla, 2011, Case Reports in Oncology.

Phase II Trial of Combined Modality Therapy with Myeloid Growth Factor Support in Patients with Locally Advanced Non-small Cell Lung Cancer

R. Lilenbaum, J. Pizzolato, M. Cusnir, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The mutational landscape of upper gastrointestinal adenocarcinomas- A study of similarities and differences.

R. Poppiti, M. Cusnir, M. Schwartz, 2021, Pathology, research and practice.

Advances in Cholangiocarcinoma Treatment in the Personalized Medicine Era

M. Cusnir, K. Dvir, G. G. Fortuna, 2020, Open Journal of Hepatology.

789 Lifileucel TIL cell monotherapy in patients with advanced melanoma after progression on immune checkpoint inhibitors (ICI) and targeted therapy: pooled analysis of consecutive cohorts (C-144–01 study)

J. Kirkwood, P. Hari, H. Kluger, 2022, Regular and Young Investigator Award Abstracts.

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

J. Berlin, A. Jimeno, D. Aisner, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.

M. Cusnir, Antonio E Martinez, D. Peker, 2012, Clinical advances in hematology & oncology : H&O.

An Occult Malignancy Behind a Demyelinating Disease

M. Cusnir, D. Morlote, Saberio Lo Presti, 2016, Journal of investigative medicine high impact case reports.

Inter-tumor heterogeneity

M. Cusnir, Mike Cusnir, Ludmila Cavalcante, 2012, Human vaccines & immunotherapeutics.

Gastric Small-Cell Carcinoma Found on Esophagogastroduodenoscopy: A Case Report and Literature Review

S. Zeichner, M. Cusnir, M. Francavilla, 2013, Case reports in oncological medicine.

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

J. Berlin, A. Jimeno, D. Aisner, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Diffuse large b-cell lymphoma with hemophagocytic syndrome in an HIV+ patient treated with CCR5- bone marrow transplant

M. Cusnir, C. Tuda, Vathany Sriganeshan, 2014 .

A De Novo Germline APC Mutation (3927del5) in a Patient with Familial Adenomatous Polyposis: Case Report and Literature Review

S. Zeichner, M. Cusnir, M. Francavilla, 2012, Clinical Medicine Insights. Oncology.

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

Michael E. Egger, J. Kirkwood, P. Hari, 2022, Journal for ImmunoTherapy of Cancer.

Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.

R. Goldberg, M. Tempero, P. Enzinger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Title- Genomic landscape of squamous cell carcinoma- Different genetic pathways culminating in a common phenotype.

R. Poppiti, M. Cusnir, Vathany Sriganeshan, 2020, Cancer treatment and research communications.

Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel

Catalin C. Barbacioru, C. Barbacioru, M. Fakih, 2019, Clinical Cancer Research.

Novel ATM Gene c.5644 C > T (p.Arg1882*) Variant Detected in a Patient with Pancreatic Adenocarcinoma and Two Primary Non-Small Cell Lung Adenocarcinomas: A Case Report

H. Bahmad, M. Cusnir, A. Medina, 2022, Diseases.

The effects of physical activity on cancer prevention, treatment and prognosis: A review of the literature.

Omar Issa, Christos G Mihos, Orlando Santana, 2019, Complementary therapies in medicine.

Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas.

R. Poppiti, M. Cusnir, Vathany Sriganeshan, 2020, Pathology, research and practice.

Splenic Rupture Secondary to Amyloidosis: A Case Report and Review of the Literature

H. Bahmad, M. Cusnir, Vathany Sriganeshan, 2023, Hematology reports.

Treatment of taste alterations in chemotherapy patients using the "miracle fruit": Preliminary analysis of a pilot study.

J. Beaumont, D. Eton, H. Soares, 2010 .

Management of Locally Advanced Rectal Cancer: ASCO Guideline.

L. Kachnic, M. Chalabi, J. Loree, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.